NO995643L - Nye 4-substituerte piperidiner - Google Patents

Nye 4-substituerte piperidiner

Info

Publication number
NO995643L
NO995643L NO995643A NO995643A NO995643L NO 995643 L NO995643 L NO 995643L NO 995643 A NO995643 A NO 995643A NO 995643 A NO995643 A NO 995643A NO 995643 L NO995643 L NO 995643L
Authority
NO
Norway
Prior art keywords
new
substituted piperidines
piperidines
substituted
Prior art date
Application number
NO995643A
Other languages
English (en)
Other versions
NO314401B1 (no
NO995643D0 (no
Inventor
Venero Aurelio Orjales
Avello Antonio Toledo
Duran Carmen Pumar
Original Assignee
Faes Fabrica Espanola De Produ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Fabrica Espanola De Produ filed Critical Faes Fabrica Espanola De Produ
Publication of NO995643D0 publication Critical patent/NO995643D0/no
Publication of NO995643L publication Critical patent/NO995643L/no
Publication of NO314401B1 publication Critical patent/NO314401B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19995643A 1998-11-18 1999-11-17 Nye, 4-substituerte piperidiner, farmasöytisk preparat inneholdende disse og anvendelse av dem for fremstilling av et medikament NO314401B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.

Publications (3)

Publication Number Publication Date
NO995643D0 NO995643D0 (no) 1999-11-17
NO995643L true NO995643L (no) 2000-05-19
NO314401B1 NO314401B1 (no) 2003-03-17

Family

ID=8305832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995643A NO314401B1 (no) 1998-11-18 1999-11-17 Nye, 4-substituerte piperidiner, farmasöytisk preparat inneholdende disse og anvendelse av dem for fremstilling av et medikament

Country Status (21)

Country Link
EP (1) EP1002794B1 (no)
JP (1) JP4667552B2 (no)
KR (1) KR100646675B1 (no)
AR (1) AR028805A1 (no)
AT (1) ATE422199T1 (no)
AU (1) AU757177B2 (no)
BR (1) BR9905634B1 (no)
CA (1) CA2288533C (no)
CY (1) CY1108955T1 (no)
CZ (1) CZ296053B6 (no)
DE (1) DE69940378D1 (no)
DK (1) DK1002794T3 (no)
ES (2) ES2157148B1 (no)
HR (1) HRP990354B1 (no)
HU (1) HU227558B1 (no)
IL (1) IL132862A0 (no)
NO (1) NO314401B1 (no)
PL (1) PL196329B1 (no)
PT (1) PT1002794E (no)
RU (1) RU2232753C2 (no)
TR (1) TR199902839A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003227519A1 (en) * 2002-05-30 2003-12-19 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
UA77536C2 (en) * 2002-07-03 2006-12-15 Lundbeck & Co As H Secondary aminoaniline piperidines as mch1 antagonists and their use
KR20050071647A (ko) * 2002-11-01 2005-07-07 뉴로서치 에이/에스 신규한 피페리딘 유도체 및 모노아민 신경전달물질 재흡수억제제로서의 이의 용도
WO2005092885A1 (en) * 2004-02-27 2005-10-06 Eli Lilly And Company 4-amino-piperidine derivatives as monoamine uptake inhibitors
AU2005265093A1 (en) 2004-06-18 2006-01-26 Wyeth Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
EP1854785A1 (en) * 2006-05-12 2007-11-14 Faes Farma, S.A. 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
WO2008023258A1 (en) * 2006-08-23 2008-02-28 Pfizer Products Inc. Piperidine derivatives
NZ592543A (en) * 2008-11-14 2013-02-22 Theravance Inc 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
JP2012524098A (ja) * 2009-04-15 2012-10-11 セラヴァンス， インコーポレーテッド ３−（フェノキシピロリジン−３−イル−メチル）ヘテロアリール、３−（フェニルピロリジン−３−イルメトキシ）ヘテロアリールおよび３−（ヘテロアリールピロリジン−３−イルメトキシ）ヘテロアリール化合物
EP2390248A1 (en) 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
MA34327B1 (fr) 2010-05-24 2013-06-01 Faes Farma S A A Spanish Corp Dérivés de flufénoxine pour le traitement et la prévention des pathologies amyloïdes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体
AUPN037195A0 (en) * 1995-01-03 1995-01-27 Australian Nuclear Science & Technology Organisation Piperidine-based sigma receptor ligands
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina

Also Published As

Publication number Publication date
TR199902839A3 (tr) 2000-09-21
EP1002794A1 (en) 2000-05-24
KR20000035525A (ko) 2000-06-26
ES2323742T3 (es) 2009-07-23
CA2288533C (en) 2009-01-06
NO314401B1 (no) 2003-03-17
CA2288533A1 (en) 2000-05-18
DK1002794T3 (da) 2009-04-14
HUP9904086A2 (hu) 2000-11-28
HRP990354A2 (en) 2000-06-30
CY1108955T1 (el) 2014-07-02
ATE422199T1 (de) 2009-02-15
KR100646675B1 (ko) 2006-11-17
ES2157148B1 (es) 2002-03-01
JP4667552B2 (ja) 2011-04-13
IL132862A0 (en) 2001-03-19
BR9905634B1 (pt) 2012-09-04
BR9905634A (pt) 2000-09-26
AU757177B2 (en) 2003-02-06
AR028805A1 (es) 2003-05-28
DE69940378D1 (de) 2009-03-19
JP2000154176A (ja) 2000-06-06
HRP990354B1 (en) 2008-11-30
NO995643D0 (no) 1999-11-17
CZ296053B6 (cs) 2005-12-14
HUP9904086A3 (en) 2001-11-28
RU2232753C2 (ru) 2004-07-20
ES2157148A1 (es) 2001-08-01
HU227558B1 (en) 2011-08-29
PT1002794E (pt) 2009-03-25
HU9904086D0 (en) 2000-01-28
CZ399599A3 (cs) 2000-08-16
PL336607A1 (en) 2000-05-22
PL196329B1 (pl) 2007-12-31
TR199902839A2 (xx) 2000-09-21
AU5936699A (en) 2000-05-25
EP1002794B1 (en) 2009-02-04

Similar Documents

Publication Publication Date Title
NO20033715L (no) Nye sammensetninger
NO20014518D0 (no) Nye forbindelser
NO20020283L (no) Nye forbindelser
NO20003347L (no) Nye makrolider
NO20021436L (no) Nye forbindelser
NO20026125L (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
NO20012339L (no) Nye piperazin- og piperidinforbindelser
DE60000003D1 (de) Paroxetinmethansulfonat
NO20020810L (no) Nye fenylpiperaziner
NO20015074L (no) Nye sammensetninger
NO20015383D0 (no) Nye forbindelser
NO20010860D0 (no) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
NO995643L (no) Nye 4-substituerte piperidiner
NO20005857L (no) Nye blandinger
NO20015374D0 (no) Nye forbindelser
NO995945D0 (no) Nye forbindelser
NO20013601D0 (no) Nye morfolinobenzamidsalter
NO20010584L (no) Nye forbindelser
NO20014629L (no) Nye forbindelser
NO20005681D0 (no) Nye formuleringer som inneholder paroxetin
NO20011262L (no) Nye forbindelser
NO20016273L (no) Nye forbindelser
DE60139781D1 (de) 4-substituierte piperidinverbindung
DK1037892T3 (da) Piperidinderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees